ERBB2 and neoplasm: In this study, we investigated the clinicopathological characteristics and the frequency of co-occurrence of the CDH1 mutation and tumour-infiltrating lymphocytes (TILs) in 35 ERBB2-mutated BCs via a public database (TCGA-BRCA).